Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityNo recent work listed

Jinggang Mo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3538-4326; OpenAlex author ID A5018158980. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: 1 paper

Papers 3

  1. Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment. Co-author DOI 10.2147/dddt.s323360↗
  2. Nobiletin flavone inhibits the growth and metastasis of human pancreatic cancer cells via induction of autophagy, G0/G1 cell cycle arrest and inhibition of NF-… Co-author PMID 32521908↗
  3. Recombinant human adenovirus-p53 improves the outcome of mid-late stage pancreatic cancer via arterial infusion. Co-author DOI 10.3892/ol.2017.7058↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiongying Miao · 1 shared paper, 2021 · strength 0.15
  2. Kunpeng Wang · 1 shared paper, 2021 · strength 0.15
  3. Yanwen Zheng · 1 shared paper, 2021 · strength 0.15
  4. Fanhua Kong · 1 shared paper, 2021 · strength 0.15
  5. Hao Jiang · 1 shared paper, 2020 · strength 0.15
  6. Haiou Wang · 1 shared paper, 2020 · strength 0.15
  7. Weidong Lin · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.